Research
Hormonal
Glucagon-like peptide (GLP-1) receptor agonists may induce generalized weight loss but may not effectively target visceral abdominal fat.
GLP-1 receptor agonists may not be the best choice for targeting visceral fat in HIV patients.
StrongQualifiesmedium confidence
GLP-1 receptor agonists, which induces generalized weight loss in a nonspecific way.
Why this rating
The abstract provides evidence from case presentations regarding the effects of GLP-1.
Source
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists
Robin Beach et al. · Clinical Infectious Diseases · 2026
case_study · n=2Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →